Cargando…

Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment

SIMPLE SUMMARY: Cancer is a major global health concern, with the Mitogen-activated protein kinase (MAPK) pathway playing a crucial role in cancerous diseases. Indole alkaloids, such as vincristine and evodiamine, have been extensively studied for their potential in cancer treatment. These naturally...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Amin, Md., Emran, Talha Bin, Khan, Jishan, Zehravi, Mehrukh, Sharma, Indu, Patil, Anasuya, Gupta, Jeetendra Kumar, Jeslin, D., Krishnan, Karthickeyan, Das, Rajib, Nainu, Firzan, Ahmad, Irfan, Wilairatana, Polrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670446/
https://www.ncbi.nlm.nih.gov/pubmed/38001572
http://dx.doi.org/10.3390/cancers15225311
_version_ 1785139924993835008
author Al Amin, Md.
Emran, Talha Bin
Khan, Jishan
Zehravi, Mehrukh
Sharma, Indu
Patil, Anasuya
Gupta, Jeetendra Kumar
Jeslin, D.
Krishnan, Karthickeyan
Das, Rajib
Nainu, Firzan
Ahmad, Irfan
Wilairatana, Polrat
author_facet Al Amin, Md.
Emran, Talha Bin
Khan, Jishan
Zehravi, Mehrukh
Sharma, Indu
Patil, Anasuya
Gupta, Jeetendra Kumar
Jeslin, D.
Krishnan, Karthickeyan
Das, Rajib
Nainu, Firzan
Ahmad, Irfan
Wilairatana, Polrat
author_sort Al Amin, Md.
collection PubMed
description SIMPLE SUMMARY: Cancer is a major global health concern, with the Mitogen-activated protein kinase (MAPK) pathway playing a crucial role in cancerous diseases. Indole alkaloids, such as vincristine and evodiamine, have been extensively studied for their potential in cancer treatment. These naturally occurring indole alkaloids have strong anticancer properties, and research is ongoing to develop new anticancer small molecules. The current review aims to evaluate how indole alkaloids affect the MAPK signaling pathway in cancer treatment and focus on advancements in the role of indole alkaloids. The review also highlights clinical trials with indole alkaloids in cancer treatment. ABSTRACT: Cancer is the leading cause of morbidity and mortality in people throughout the world. There are many signaling pathways associated with cancerous diseases, from which the Mitogen-activated protein kinase (MAPK) pathway performs a significant role in this regard. Apoptosis and proliferation are correlated with MAPK signaling pathways. Plenty of experimental investigations were carried out to assess the role of indole alkaloids in MAPK-mediated cancerous diseases. Previous reports established that indole alkaloids, such as vincristine and evodiamine are useful small molecules in cancer treatment via the MAPK signaling system. Indole alkaloids have the anticancer potential through different pathways. Vincristine and evodiamine are naturally occurring indole alkaloids that have strong anticancer properties. Additionally, much research is ongoing or completed with molecules belonging to this group. The current review aims to evaluate how indole alkaloids affect the MAPK signaling pathway in cancer treatment. Additionally, we focused on the advancement in the role of indole alkaloids, with the intention of modifying the MAPK signaling pathways to investigate potential new anticancer small molecules. Furthermore, clinical trials with indole alkaloids in cancer treatment are also highlighted.
format Online
Article
Text
id pubmed-10670446
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106704462023-11-07 Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment Al Amin, Md. Emran, Talha Bin Khan, Jishan Zehravi, Mehrukh Sharma, Indu Patil, Anasuya Gupta, Jeetendra Kumar Jeslin, D. Krishnan, Karthickeyan Das, Rajib Nainu, Firzan Ahmad, Irfan Wilairatana, Polrat Cancers (Basel) Review SIMPLE SUMMARY: Cancer is a major global health concern, with the Mitogen-activated protein kinase (MAPK) pathway playing a crucial role in cancerous diseases. Indole alkaloids, such as vincristine and evodiamine, have been extensively studied for their potential in cancer treatment. These naturally occurring indole alkaloids have strong anticancer properties, and research is ongoing to develop new anticancer small molecules. The current review aims to evaluate how indole alkaloids affect the MAPK signaling pathway in cancer treatment and focus on advancements in the role of indole alkaloids. The review also highlights clinical trials with indole alkaloids in cancer treatment. ABSTRACT: Cancer is the leading cause of morbidity and mortality in people throughout the world. There are many signaling pathways associated with cancerous diseases, from which the Mitogen-activated protein kinase (MAPK) pathway performs a significant role in this regard. Apoptosis and proliferation are correlated with MAPK signaling pathways. Plenty of experimental investigations were carried out to assess the role of indole alkaloids in MAPK-mediated cancerous diseases. Previous reports established that indole alkaloids, such as vincristine and evodiamine are useful small molecules in cancer treatment via the MAPK signaling system. Indole alkaloids have the anticancer potential through different pathways. Vincristine and evodiamine are naturally occurring indole alkaloids that have strong anticancer properties. Additionally, much research is ongoing or completed with molecules belonging to this group. The current review aims to evaluate how indole alkaloids affect the MAPK signaling pathway in cancer treatment. Additionally, we focused on the advancement in the role of indole alkaloids, with the intention of modifying the MAPK signaling pathways to investigate potential new anticancer small molecules. Furthermore, clinical trials with indole alkaloids in cancer treatment are also highlighted. MDPI 2023-11-07 /pmc/articles/PMC10670446/ /pubmed/38001572 http://dx.doi.org/10.3390/cancers15225311 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Al Amin, Md.
Emran, Talha Bin
Khan, Jishan
Zehravi, Mehrukh
Sharma, Indu
Patil, Anasuya
Gupta, Jeetendra Kumar
Jeslin, D.
Krishnan, Karthickeyan
Das, Rajib
Nainu, Firzan
Ahmad, Irfan
Wilairatana, Polrat
Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment
title Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment
title_full Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment
title_fullStr Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment
title_full_unstemmed Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment
title_short Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment
title_sort research progress of indole alkaloids: targeting map kinase signaling pathways in cancer treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670446/
https://www.ncbi.nlm.nih.gov/pubmed/38001572
http://dx.doi.org/10.3390/cancers15225311
work_keys_str_mv AT alaminmd researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT emrantalhabin researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT khanjishan researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT zehravimehrukh researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT sharmaindu researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT patilanasuya researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT guptajeetendrakumar researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT jeslind researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT krishnankarthickeyan researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT dasrajib researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT nainufirzan researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT ahmadirfan researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment
AT wilairatanapolrat researchprogressofindolealkaloidstargetingmapkinasesignalingpathwaysincancertreatment